Skip to content
Medical Health Aged Care, Science

Grant to boost research into age-related blood vessel health

Centenary Institute 2 mins read

The Centenary Institute’s Professor Jennifer Gamble has been awarded a Senior Researcher Grant under the NSW Cardiovascular Research Capacity Program receiving a total of $750,000 over three years. The grant will fund Professor Gamble’s research into vascular (blood vessel) health to aid healthy ageing and to help prevent disease.


Under the grant, Professor Gamble will lead ground-breaking research to deepen understanding of the ageing process while developing innovative therapeutic approaches to tackle age-related vascular diseases, including Alzheimer’s, cerebral amyloid angiopathy (the build-up of abnormal proteins in brain blood vessels) and atherosclerosis (the build-up of fatty deposits in arteries).


Professor Gamble, a senior researcher in the Centenary Institute’s Centre for Healthy Ageing said that age is the greatest risk factor for vascular diseases, with endothelial cell dysfunction serving as a significant driver.


“Endothelial cells are the cells that line blood vessels. They play a critical role in disease because they orchestrate blood flow, help regulate the body’s immune response and also maintain vascular health,” said Professor Gamble.


“Our research will focus on mitigating the detrimental ageing process of endothelial cells to improve health outcomes and to also potentially combat some of the most devastating vascular diseases affecting society today.”


Research to be undertaken by Professor Gamble will initially explore how aged endothelial cells contributes to diseases at the molecular level. Subsequently, she will investigate three separate drugs aimed at repairing aged blood vessels, to reduce the risk of age-related vascular diseases.


According to Professor Marc Pellegrini, Executive Director of the Centenary Institute, the successful research grant underscores the Institute’s commitment to innovative research addressing substantial global health challenges, particularly in the context of a rapidly aging population.


“As our population ages swiftly, age-related diseases pose escalating economic and societal challenges both in Australia and worldwide,” said Professor Pellegrini.


“Professor Gamble’s crucial research will not only contribute to fundamental knowledge concerning vascular disease but also bears the potential for positive implications in fostering healthier ageing on a global scale.”


The NSW Cardiovascular Research Capacity Program funds high quality cardiovascular research in NSW in order to drive scientific discoveries, support the development of novel and innovative therapies, and improve health outcomes for patients with cardiovascular disease.




About us:

About the Centenary Institute

The Centenary Institute is a world-leading independent medical research institute, closely affiliated to the University of Sydney and the Royal Prince Alfred Hospital. Our research spans the critical areas of cancer, cardiovascular disease, rare diseases, inflammation, infectious diseases, healthy ageing and biomedical AI. Our strength lies in uncovering disease mechanisms and applying this knowledge to improve diagnostics and treatments for patients.


For more information about the Centenary Institute, visit


Contact details:

For all media and interview enquiries, please contact

Tony Crawshaw, Media and Communications Manager, Centenary Institute on 0402 770 403 or email:


More from this category

  • Medical Health Aged Care
  • 20/04/2024
  • 04:30
Dementia Australia

Join us TODAY for Bendigo Memory Walk & Jog

What: Dementia Australia’sBendigoMemory Walk & Jog When: Saturday 20 April, from 8am Who: More than 390 locals participating on the day. People who have been impacted by dementia, their family, friends and carers. Where: Bendigo Botanic Gardens, Bendigo For more information visit: Walk or jog with us. We are in this together. Dementia Australia is the source of trusted information, education and services for the estimated more than 421,000 Australians living with dementia, and the more than 1.6 million people involved in their care. We advocate for positive change and support vital research. We are here to support people…

  • Contains:
  • Medical Health Aged Care, Science
  • 19/04/2024
  • 15:00
Monash University

Large-scale genetic study finds new link between Irritable Bowel Syndrome and the cardiovascular system

New research published today in the journal Cellular and Molecular Gastroenterology and Hepatology sheds light on disease mechanisms common to irritable bowel syndrome (IBS) and cardiovascular diseases (CVD). Led by Dr Leticia Camargo Tavares, a Postdoctoral Fellow at the Hypertension Research Laboratory within Monash University’s School of Biological Sciences, the study reveals novel insights into the genetic underpinnings of IBS, offering potential avenues for therapeutic intervention. IBS is one of the most prevalent gastrointestinal disorders globally, affecting up to 10 per cent of the population, with a disproportionate impact on women. It is characterised by a complex range of symptoms…

  • Medical Health Aged Care
  • 19/04/2024
  • 11:13
Gilead Sciences Australia

Australian community organisations addressing viral hepatitis receive AU$400,000 via global Gilead ALL4LIVER Grant program

– Gilead Sciences joins forces with World Hepatitis Alliance and experts to drive progress on viral hepatitis elimination targets – – Australian initiatives well represented in Gilead’s US$4 million global fund to empower local communities in the fight against viral hepatitis – Melbourne, Australia, 19 April 2024 – Today, on World Liver Day, Gilead Sciences Australia has announced nine local community organisations addressing viral hepatitis will receive a combined AU$400,000 via the global Gilead ALL4LIVER Grant. The recipients were selected by an independent external review panel of global experts, including the World Hepatitis Alliance. Australia has committed to achieving the…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.